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Abstract 
Aim: To examine peripheral blood and 
skeletal muscle from patients with chronic 
fadgue syndrome for exogenous retro-
virus. 
Methods: Blood samples from 30 patients 
and muscle biopsy specimens of 15 
patients were examined for retroviral 
sequences by DNA extraction, polymerase 
chain reacdon (PCR), and Southern blot-
ting hybridisation. Sera were examined 
for human foamy virus by western immu-
noblotting and indirect immunofluores-
cence techniques. 
Results: No difference between the padent 
and control populations was found for any 
of the PCR primer sets used (gag, pol, 
env, and tax regions of HTLV VII). An 
endogenous gag band was observed in 
both the padent and control groups. All 
sera were negative for antibody to human 
foamy virus. 
Conclusion: The results indicate that 
there is no evidence of retroviral involve-
ment in the chronic fatigue syndrome. 
(JC/in Patho/1992;45:1058-1061) 
The postviral fatigue syndrome, also known as 
the chronic fatigue and immune dysfunction 
syndrome (CFIDS), is a disorder of unknown 
aetiology, characterised by severe fatigue 
together with myalgia. 1 2 Its investigation has 
been difficult because of the Iack of objective 
clinical laboratory findings, but strict diag-
nostic criteria have now been established so 
that appropriate studies can be made.' 4 The 
disease occurs in epidemics, whe~e it has been 
reported under a variety of names such as 
neuromyasthenia and benign encephalomyeli-
tis, 2 but it is also endemic and single cases now 
present much more commonly. 5 No one virus 
was ever isolated from the epidemic cases. 7 
Because of the clinical similarity with the 
chronic mononucleosis syndrome, Epstein-
Barr virus bad been considered a likely agent, 
but recent studies have ruled out this possibil-
ity, showing no correlation between the pres-
ence of chronic fatigue and increased antibody 
titres to the Epstein-Barr virus. 6 
The enteroviruses, especially Coxsackie 
viruses have often been thought to have a role. 1 
We looked for enteroviral genomes in the 
muscle biopsy specimens of a large number of 
weil characterised patients with postviral 
fatigue syndrome and identified enteroviral 
specific nucleic acid sequences in 53% of 
patients, compared with 15% of age and sex 
matched controls. 
Numerousimmunological abnormalitieshave 
also been demonstrated in these patients, 1 8 
but whether these are primary immune 
defects, · leading to the establishment of a 
chronic infection, or produced secondarily by a 
viral infection, has not been determined. None 
the less the deficiencies identified led a group 
at the Wistar Institute in Philadelphia to search 
for evidence of retroviral involvement in the 
disease. They reported that examination of 
peripheral blood samples provided positive 
evidence of a human T lymphotropic-like virus 
in most of the patients and they postulated a 
causal relation. 9 
We studied a group of weil characterised 
patients with postviral fatigue syndrome from 
the West of Scotland, to determine if an 
exogenous retrovirus was present. We exam-
ined peripheral blood mononuclear cells and . 
muscle biopsy specimens at the nucleic acid 
Ievel using gene amplification in each of the 
four regions of the retroviral genome by means 
of the polymerase chain reaction (PCR), fol-
lowed by Southern blot hybridisation. Because 
of the very recent suggestion (by Professor W 
John Martin, personal communication, 
National Chronic Fatigue Syndrome Advisory 
Council, CDC, Atlanta, September 1991) that 
another retrovirus, the human foamy virus, 
might be associated with postviral fatigue 
syndrome, we also looked for specific anti-
hodies to this virus in the serum of patients and 
controls, using westem immunobloning and 
indirect immunofluorescence techniques. 
Methods 
Thirty patients who fulfilled the criteria estab-
lished for postviral fatigue syndrome and 
CFIDS were studied. 4 They all complained of 
severe fatigue, which was made worse by 
exercise and. bad been present for more than a 
year. They were admitted as inpatients so as to 
exclude all the other conditions which enter 
into the differential diagnosis of the syndrome. 
None bad received blood transfusions. 
The control group consisted of 30 age and 
sex matched subjects, of whom 15 were 
healthy volunteers and 15 bad other neuro-
logical or muscular disorders, (migraine 
(n = 5), epilepsy (n = 2), rheumatoid arthri-
tis (n = 3) and systemic Iupus erythematosus 
(n = 5)). 
Peripheral blood and muscle biopsy samples 
were coded by a person not involved in the 
experiments. Blood (20 ml) was taken from 
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patients and controls and peripheral blood 
mononuclear cells (PBMC) were isolated. The 
serum was stored at - 7o·c until required. 
Museie biopsy samples were taken from the 
right vastus lateralis of all patients with post-
viral fatigue syndrome and the 15 patients with 
other neuromuscular disorders, using the 
UCH biopsy needle to obtain two cores of 
skeletal muscle. These were snap frozen in 
liquid nitrogen and stored till use. 
To reduce the risk of Iabaratory contamina-
tion, amplification of coded samples was car-
ried out under strict Containment procedures. 
High molecular weight DNA was prepared 
from PBMC and skeletal muscle, as des-
cribed.10 The preservation of the DNA was 
assured by amplifying a 1 pg aliquot with a 
control cellular gene, endogenaus tyrosine 
kinase, using ABL gene primers. 7 Only those 
samples that gave a positive ABL gene band 
were used for analysis with retroviral primers. 
The primers used for PCR amplification and 
the probes used to detect amplified sequences 
were selected from four regions, gag, tax, pol 
and env of the retroviral genome. 
(1) Two sets of gag primers for HTLV-11 were 
used, the first as described in the previous 
positive study9 and consisting of nucleo-
tides 807-40 and 1214-87. The probe, 
also as described, 9 spanned nucleotides 
1080-1105. Plasmid PMT2 (encoding 
HTLV-1 sequence) was also used as a 
probe for this primer set and for the 
second primer set which was synthesised 
in our Iabaratory and consisted of nucleo-
tides 1374-98 and 1573-97. 
(2) The two pol primers SKllO and SKlll 
were obtained from Cetus. 1 1 They amplify 
sequences common to the pol regions of 
HTLV-1 and II. Two specific internal 
probes SK112 and SK118 (Cetus) were 
used. 11 
(3) The two env primers consisted of nucleo-
tides 5689-5713 and 6002-6026, syn-
thesised in our laboratory. These amplify 
sequences in HTLV-11. 
( 4) The two tax primers SK43 and SK44 were 
obtained from Cetus. 1 1 They would be 
expected to amplify sequences from the 
tax regions of both HTLV-1 and II. No 
probe was used because the PCR results 
were negative. 
PCR Amplification and hybridisation results in 30 patients wich postviral fatigue 
syndrome and 30 contro/ subjects 
PCR resu/c Probe resu/c 
Primers Pacienrs Conrrols Probe Pacients Controls 
HTLV-11 gag Positive Positive pMT2 Negative Negative 
bp 1374-98 
1573-97 
HTLV-11 gag Positive Positive pMT2 Negative Negative 
bp 807-40 
Negative Negative 1214-87(9) bp 1080-1105(9) 
HTLV 1111 pol Positive Positive SK112 Negative Negative 
SK110/111 SK118 Negative Negative 
HTLV II env Negative Negative None ND ND 
bp 5689-5713 
6002-6026 
HTLV-l/11 cax Negative Negative None ND ND 
SK43/44 
Positive contro1: pMT2 (HTLV-I)DNA was positive for both sets of gag PCR primers and 
positive in subsequent hybridisation with pMT2 and the basepair 1080-1105 gag probe. 
nd = not done. 
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The cell line C8166 was used as a positive 
control. It is an HTLV-I transformed cellline 
and does not release infectious virions. 1 2 Titra-
tion experiments using this control and an 
uninfected cell line confirmed that one infec-
ted target cell in about 100 000 infected cells 
could be detected. Repeat experiments were 
performed with a variety of Taq polymerase 
enzymes and buffers from Promega (South-
ampton, England), du Pont (Hertfordshire, 
England) and Perkin-Eimer Centre (Buck-
inghamshire, England), to ensure that low 
copy numbers of virus would not be missed. 
DNA amplification was performed with a 
programmable Techne Cambridge heating 
block set to give 35 cycles of one minute at 
94 ·c, one minute at 55•c, and 1·2 minutes at 
12·c for all primer sets. The products were 
electrophoresed through 2% agarase gels, 
stained with ethidium bromide, and visualised 
under ultraviolet light. Gels were then immobi-
lised on a nylon membrane (GeneScreen Plus) 
and hybridised with the appropriate uP-lab-
elled internal probe. Filters were washed at low 
stringency to retain any mismatched hybrids. 
Blots were exposed for up to 21 days to Kodak 
XAR5 film with intensifying screens at 
-1o·c. 
Serum antibodies to another retrovirus, 
from the spumavirus family, the human foamy 
virus were sought by western immunoblot-
ting. 
Western blot antigen was prepared by con-
centrating human foamy virus (HFV) from the 
supernatant fluid of lytically infected baby 
hamster kidney cells (BHK-21), by the method 
of Netzer et al, 13 in the Institut für Virologie 
and Immunbiologie in Würzburg. Serum dilu-
tions of 1 in 25 were used, although positive 
sera will produce a reaction at 1 in 100. The 
positive pattern on the western blot is similar 
to that described for radioimmunoprecipita-
tion assay. 11 
The indirect immunoftuorescence assay was 
also carried out at the Institut für Virologie and 
Immunbiologie, Würzburg. Babyhamster kid-
ney cells (BHK-21) infected with human 
foamy virus were used as a substrate. The 
serum samples were tested in an indirect 
immunoftuorescence assay, as described. •·l 
Sera positive for antibodies to human foamy 
virus will produce brilliant nuclear staining of 
the infected cells. 
Results 
The results of the PCR experiments are shown 
in the table. 
The two sets of HTLV-11 gag primers gave 
rise to a specific band in all patient and control 
samples. The published gag primers nucleo-
tides 807-1287,9 gave rise to a band of 440 
base pairs in length. When the products were 
hybridised to the probe, the retroviral plasmid 
pMT2, however, no specific signalwas detec-
ted. Hybridisation of gag primer product 
807-1287 with the 85% GC-rich internal gag 
probe was also negative. No other PCR prod-
uct was detectable. The PCR product band 
should have been 409 base pairs in length for a 
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sequence of HTLV-11, and we postulate, there-
fore, that the 440 base pair band obtained 
must represent endogenaus retrovirus. 
The pol region primers also produced spe-
cific bands in all patients and controls: a 
product of about 186 base pairs was obtained 
in each case, but hybridisanon with the HTLV-
1 and HTLV-11 specific probes was negative. 
The env and tax region primer experiments 
were negative in both groups. 
Examination of the sera of the patient and 
control groups revealed no antibodies to 
human foamy virus by western blotting or 
immunofluorescence assay. 
These results provide no evidence that exog-
enaus retroviral sequences are present in 
peripheral blood cells or muscle of patients 
with postviral fatigue syndrome, nor do the 
patients have antibodies to another member of 
the retrovirus family, the human foamy virus. 
Discussion 
Our results provide no evidence of retroviral 
involvement in the chronic fatigue syndrome. 
We found no sequences indicative of the 
exogenous retroviruses HTLV-1 or II in the 
peripheral blood or muscle biopsy specimens 
of the patients and no specific antibodies in 
their serum to a spumavirus, the human foamy 
virus. 
Retroviral involvement in postviral fatigue 
syndrome was originally considered because 
this is an unusual chronic neurological disease 
with immune abnormalities and, as such, bears 
some similarity to tropical spastic paraperesis, 
a disorder in which HTLV-1 has been shown to 
be the aetiological agent. 15 
Our patient group was strictly defined. 3 4 
They each had a typical history with severe 
fatigue present for at least one year. All were 
admitted to hospital in order to exclude any 
other causes for their symptoms. As regards 
methodology, we used universal sets of primers 
which should amplify the published positive 
PCR product and other PCR products com-
mon to human retroviruses. This strategy 
should have increased the chances of detecting 
a new, related retrovirus. The specificity and 
sensitivity of the oligonucleotides were con-
firmed using a cell line infected with HTLV-1 
and showing that one infected cell in 1 00 000 
could be detected. The probes used were 
positive in the positive control hybridisation. 
Other workers have recently reported that 
retroviral sequences can be detected in a 
proportion of patients with postviral fatigue 
syndrome.9 Their patient group was charac-
terised by the same criteria as ours, but was 
from North Carolina and New York. PCR 
amplification of gene· sequences was also used 
by this group, for gag and tax regions of HTLV-
1 and II. They found that the HTLV-11 gag 
primers were positive in 20 of 28 patients, with 
seven of 10 of these cases showing confirma-
tion of positivity by specific probes in an in situ 
hybridisation study of peripheral blood mono-
nuclear cells. Sixty one per cent of the cases 
bad antiborlies to HTLV viral antigens. 
We used the same primers as the above 
workers but our results are different. The most 
important finding we made was that the gag 
primers used an'lplified a sequence in both 
patients and controls, which thus probably 
represents an endogenaus retroviral sequence. 
The disparity between our results can be 
explained because de Freitas et ar used two 
control groups, one of them being an "expo-
sure" group of individuals, in contact with an 
epidemic of postviral fatigue syndrome, or with 
affective individuals, but unaffected them-
selves. In this group there were indeed 30% of 
samples positive to the gag PCR test and 43% 
of samples positive to the HTLV western blot. 
Thus, positive results were detectable in 
patient and control groups, as in our study. 
Our interpretation is that the sequence is 
endogenous, rather than exogenous, virus. 
PCR methodology has to be used with 
caution because of its inherent weakness-its 
false positive results. 16 17 The strictest con-
taminant facilities must be used and it has to 
be recognised that sporadic, unreproducible 
signals may be generared in a few samples 
examined. Repetition, stringent analysis, and 
use of specific probes are necessary to exclude 
(or confirm) results. 17 
The situation in postviral fatigue syndrome 
bears some analogy with that for multiple 
sclerosis, where again diagnosis may be diffi-
cult and clinical course unpredictable. 
Koprowski and colleagues, 18 among others, 
originally reported retroviral involvement in 
this disease too. Their work was followed by at 
least 1 0 carefully controlled studies, carried 
out worldwide, and culminating in a huge, 
blind examination of 1 000 samples from 
patients, each of which concluded that there 
was no evidence of such a retroviral associa-
tion, when false positive results, including 
endogenaus retroviral sequences, had been 
excluded. 19 
The involvement of other viruses in postviral 
fatigue syndrome, however, is undoubtedly a 
strong possibility. We have recently reported 
that enteroviral genome can be detected in the 
muscle of 53% of these cases, compared with 
15% of control subjects. 7 Enteroviral sequen-
ces may be present in peripheral blood mono-
nuclear cells, but equally prevalent in patients 
and controls, suggesting that infection of these 
cells is related purely to the numbers of 
enteroviruses circulating in the community at 
the time. The high incidence in the muscle of 
patients~ however, which is not related tö 
peripheral blood findings, suggests that there is 
a low grade, chronic enteroviral infection ofthe 
tissue. Oldstone and bis colleagues20 have 
shown that such persistent viral infections are 
associated with interference in cell metabo-
lism. Structural abnormalities in muscle mito-
chondria has been identified in some cases of 
postviral fatigue syndrome, 21 suggesting that 
the characteristic fatigue may be related to the 
effect of chronic enteroviral or other viral 
infection on these organelles. 
From the data reported here, we cannot 
exclude the possibility that a very distantly 
related retrovirus is also associated with post-
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viral fatigue syndrome, but this seems very 
unlikely. 
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